Last reviewed · How we verify
Carphenazin (carfenazine)
At a glance
| Generic name | carfenazine |
|---|---|
| Target | 5-hydroxytryptamine receptor 2A |
| Therapeutic area | Neuroscience |
| Phase | FDA-approved |
Approved indications
- Chronic schizophrenia
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Carphenazin CI brief — competitive landscape report
- Carphenazin updates RSS · CI watch RSS
- portfolio CI